Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib
Clinical trial NCT03956940 · TERMINATED
Trial details
- NCT number
- NCT03956940
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-04
- Primary completion
- 2021-12-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.